OrthoLogic to acquire Chrysalis

OLGC will acquire tissue regeneration company Chrysalis BioTechnology (Galveston, Texas) for $2.5 million in cash and $25 million in stock. Chrysalis is eligible for milestones of $7 million in stock. OLGC already owns about 5% of Chrysalis. ...